Dry and Sensitive Skin

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Moiz MMN/A1 trial
Active Trials
NCT06678464Completed84Est. Feb 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
LabcorpMoiz MM

Clinical Trials (1)

Total enrollment: 84 patients across 1 trials

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Healthy Adult Human Subjects With Dry and Sensitive Skin.

Start: Dec 2024Est. completion: Feb 202584 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space